PharmaCyte Biotech's total assets for Q1 2026 were $45.11M, a decrease of -18.23% from the previous quarter. PMCB total liabilities were $1.52M for the fiscal quarter, a -53.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.